Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$14.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 6,400 | $35.07 | $224.4K | -0.3% | Open the original filing on SEC.gov |
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 41,276 | $34.22 | $1.4M | -1.6% | Open the original filing on SEC.gov |
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 53,279 | $33.38 | $1.8M | -2.1% | Open the original filing on SEC.gov |
| Jan 5 | VKTX | Viking Therapeutics, Inc. | SSELL | 132,454 | $32.29 | $4.3M | -4.9% | Open the original filing on SEC.gov |
| Jan 2 | VKTX | Viking Therapeutics, Inc. | AGRANT◆ | 176,300 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | VKTX | Viking Therapeutics, Inc. | AGRANT | 224,080 | — | — | +8.9% | Open the original filing on SEC.gov |
| Jan 2 | VKTX | Viking Therapeutics, Inc. | AGRANT | 78,400 | — | — | +3.2% | Open the original filing on SEC.gov |
| Oct 28, 2025 | VKTX | Viking Therapeutics, Inc. | SSELL | 38,989 | $35.01 | $1.4M | -1.6% | Open the original filing on SEC.gov |
| Oct 27, 2025 | VKTX | Viking Therapeutics, Inc. | AGRANT | 70,084 | — | — | +2.9% | Open the original filing on SEC.gov |
| Jul 3, 2025 | VKTX | Viking Therapeutics, Inc. | SSELL | 26,889 | $27.80 | $747.6K | -1.1% | Open the original filing on SEC.gov |
| Jul 2, 2025 | VKTX | Viking Therapeutics, Inc. | AGRANT | 48,333 | — | — | +2.0% | Open the original filing on SEC.gov |